Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
FENC
FENC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FENC News
Solas Capital Initiates New Position in Kyndryl
4d ago
Fool
Fennec Pharmaceuticals Initiates PEDMARK® Clinical Study
6d ago
Newsfilter
PEDMARK® Shows Promise for Hearing Preservation in Head and Neck Cancer Patients
Feb 20 2026
Newsfilter
B. Riley Begins Coverage of Fennec Pharmaceuticals Inc. with a Buy Rating and $16 Price Target
Feb 12 2026
moomoo
Southpoint Disposes 1M Shares of Fennec Pharmaceuticals, Now Holds 8% Stake
Dec 26 2025
Globenewswire
Southpoint Disposes 1M Shares of Fennec Pharmaceuticals, Now Holds 8% Stake
Dec 26 2025
Newsfilter
Southpoint Disposes 1M Shares of Fennec Pharmaceuticals, Now Holds 8% Stake
Dec 26 2025
Yahoo Finance
Fennec Pharmaceuticals Initiates Study of PEDMARK® to Reduce Ototoxicity in Adult Testicular Cancer Patients
Dec 09 2025
Newsfilter
Pedmark Shows Promising Results in Japan Study — Reduced Hearing Loss with Equivalent Cancer-Fighting Efficacy
Dec 02 2025
Benzinga
Fennec Pharmaceuticals' PEDMARK® Significantly Reduces Hearing Loss in Children
Dec 02 2025
Globenewswire
Fennec Pharmaceuticals' PEDMARK® Significantly Reduces Hearing Loss in Children
Dec 02 2025
Newsfilter
Fennec Pharmaceuticals to Participate in Piper Sandler Healthcare Conference on December 3, 2025
Nov 26 2025
Globenewswire
Fennec Pharmaceuticals Confirms Full Debt Redemption Completion
Nov 19 2025
Newsfilter
Fennec Pharmaceuticals Completes Private Placement of Common Shares in Canada
Nov 18 2025
Newsfilter
Fennec Pharmaceuticals Completes Common Shares Offering
Nov 17 2025
Yahoo Finance
Fennec Pharmaceuticals Unveils Private Sale of Common Shares in Canada
Nov 14 2025
Yahoo Finance
Show More News
